| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |